Rachel E. Geyer

Rachel E. Geyer

Auto-generated profile, based on publicly available information

Rachel E. Geyer

Department of Family Medicine, University of Washington, Seattle, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
RGRachel E Geyer
Rachel E Geyer
JKJack Henry Kotnik
Jack Henry Kotnik
VLVictoria Lyon
Victoria Lyon
EBElisabeth Brandstetter
Elisabeth Brandstetter
MSMonica Zigman Suchsland
Monica Zigman Suchsland
MTMatthew Thompson
Matthew Thompson
Background: Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. Objective: This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. Methods: We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. Results: A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. Conclusions: The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.

3 February 2023 in JMIR Formative Research
Verified
Journal Article
Open access
KMKris Pui Kwan Ma
Kris Pui Kwan Ma
KSKari A Stephens
Kari A Stephens
RGRachel E Geyer
Rachel E Geyer
MPMaria G Prado
Maria G Prado
BMBrenda L Mollis
Brenda L Mollis
YZYing Zhang
Ying Zhang
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. Objective: This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. Methods: Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. Results: Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. Conclusions: Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.

17 April 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RGRachel E. Geyer
Rachel E. Geyer
MIMoudachirou Ibikounlé
Moudachirou Ibikounlé
MEMira Emmanuel-Fabula
Mira Emmanuel-Fabula
ARAmy Roll
Amy Roll
EAEuripide Avokpaho
Euripide Avokpaho
AMArianna Rubin Means
Arianna Rubin Means
The World Health Organization’s Neglected Tropical Disease Roadmap has accelerated progress towards eliminating select neglected tropical diseases (NTDs). This momentum has catalyzed research to determine the feasibility of interrupting transmission of soil-transmitted helminths (STH) using community-wide mass drug administration (MDA). This study aims to identify potential gender-specific facilitators and barriers to accessing and participating in community-wide STH MDA, with the goal of ensuring programs are equitable and maximize the probability of interrupting STH transmission. This research was conducted prior to the launch of community-wide MDA for STH in Comé, Benin. A total of 10 focus group discussions (FGDs) were conducted separately among 40 men, 38 women, and 15 community drug distributors (CDDs). Salient themes included: both men and women believe that community-wide MDA would reduce the financial burden associated with self-treatment, particularly for low income adults. Community members believe MDA should be packaged alongside water, sanitation, and other health services. Women feel past community-wide programs have been disorganized and are concerned these distributions will be similar. Women also expressed interest in increased engagement in the implementation of future community-based public health programs. Men often did not perceive themselves to be at great risk for STH infection and did not express a high demand for treatment. Finally, the barriers discussed by CDDs generally did not align with gender-specific concerns, but rather represented concerns shared by both genders. A door-to-door distribution strategy for STH MDA is preferred by women in this study, as this platform empowers women to participate as health decision makers for their family. In addition, involving women in planning and implementation of community-wide programs may help to increase treatment coverage and compliance. Soil-transmitted helminths (STH) affect an estimated 1.5 billion people globally. The DeWorm3 Project is investigating if it is possible to interrupt transmission of STH with community-wide deworming of individuals of all ages. We conducted focus group discussions with adult men, women, and community drug distributors (CDDs) in Comé, Benin to identify gender-specific facilitators and barriers to accessing and participating in community-wide mass drug administration (MDA) programs. Our findings suggest that door-to-door community-wide MDA may not only improve MDA treatment coverage by increasing access but may also empower women by facilitating increased decision making on behalf of their regarding who is treated and where. Additionally, women may be an untapped resource for strategically reaching missed populations and women reported seeking increased involvement within the deworming of their families. Men did not perceive themselves to be at risk and thus did not have high demand for deworming. Both genders reported that they struggle to afford deworming drugs outside of MDA and that MDA coverage would be higher if treatment was integrated with water and sanitation services. Finally, CDDs generally identified only barriers and facilitators to MDA that were shared by both genders and may require more training to ensure MDA programs are equitable and effectively engage all at risk populations.

22 November 2022 in Academic Emergency Medicine
Verified
Journal Article
Closed access
AGAlexzandra T. Gentsch
Alexzandra T. Gentsch
JBJonathan Butler
Jonathan Butler
KOKelli O'Laughlin
Kelli O'Laughlin
SEStephanie A. Eucker
Stephanie A. Eucker
ACAnnaMarie Chang
AnnaMarie Chang
RRRobert M. Rodriguez
Robert M. Rodriguez

5 May 2024 in Academic Emergency Medicine
Verified
Journal Article
Closed access
RMRene Monzon
Rene Monzon
COCarolina Ornelas‐Dorian
Carolina Ornelas‐Dorian
SEStephanie A. Eucker
Stephanie A. Eucker
KRKristin Rising
Kristin Rising
KOKelli N. O'LAughlin
Kelli N. O'LAughlin
RRRobert M. Rodriguez
Robert M. Rodriguez

8 August 2022 in JMIR Preprints
Verified
Preprint
Open access
KMKris Pui Kwan Ma
Kris Pui Kwan Ma
KSKari A. Stephens
Kari A. Stephens
RGRachel Geyer
Rachel Geyer
BMBrenda L. Mollis
Brenda L. Mollis
SZSusan M. Zbikowski
Susan M. Zbikowski
YZYing Zhang
Ying Zhang
BACKGROUND Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. OBJECTIVE This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. METHODS Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. RESULTS Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. CONCLUSIONS Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.